Sammanfattning
The largest Ebola epidemic ever is about to end. No major breakthrough in terms of specific treatment has been seen, but a
number of valuable lessons have been learned, including the potential of intensive supportive care. New products are under
development, but clinical trials were initiated late in the epidemic leading to inability to include sufficient numbers. Several large
vaccine trials are underway with one vaccine so far showing 100 percent efficacy. A paradigm shift in accelerated testing of
drugs and vaccines during an ongoing epidemic is emerging.